Acrospire Investment Management LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$26,000
-27.8%
1,451
-40.8%
0.02%
-20.0%
Q1 2017$36,000
-23.4%
2,451
-3.9%
0.03%
+57.9%
Q4 2016$47,000
-56.5%
2,551
-55.2%
0.02%
-73.6%
Q3 2016$108,000
-0.9%
5,691
-16.2%
0.07%
-11.1%
Q2 2016$109,000
+109.6%
6,791
+57.5%
0.08%
+125.0%
Q1 2016$52,0004,3120.04%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders